Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Clinical Nutrition

• Publication date

  2008-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/AJCN/87.4.863PMID 18400708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells.

  2007cited by this paper
• Naringin is a Major and Selective Clinical Inhibitor of Organic Anion‐Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice

  2007cited by this paper
• Clinical relevance of the small intestine as an organ of drug elimination: drug–fruit juice interactions

  2007cited by this paper
• Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells.

  2007cited by this paper
• One Tangerine/Grapefruit Hybrid (Tangelo) Contains Trace Amounts of Furanocoumarins at a Level Too Low To Be Associated with Grapefruit/Drug Interactions

  2006cited by this paper
• A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction.

  2006influential reference
• Two Major Grapefruit Juice Components Differ in Time to Onset of Intestinal CYP3A4 Inhibition

  2005cited by this paper
• CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B

  2005cited by this paper
• Undesirable Effects of Citrus Juice on the Pharmacokinetics of Drugs

  2005cited by this paper
• Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5

  2005cited by this paper
• Food–drug interaction: grapefruit juice augments drug bioavailability—mechanism, extent and relevance

  2004cited by this paper
• TWO MAJOR GRAPEFRUIT JUICE COMPONENTS DIFFER IN INTESTINAL CYP3A4 INHIBITION KINETIC AND BINDING PROPERTIES

  2004cited by this paper
• Therapeutic drug monitoring of cyclosporine: 20 years of progress.

  2004cited by this paper
• Contributions of CYP3A4, P-glycoprotein, and Serum Protein Binding to the Intestinal First-Pass Extraction of Saquinavir

  2004influential reference
• Effects of grapefruit juice and orange juice components on P‐glycoprotein‐ and MRP2‐mediated drug efflux

  2004influential reference
• P-glycoprotein: from genomics to mechanism

  2003cited by this paper
• The effects of fruit juices on drug disposition: a new model for drug interactions

  2003cited by this paper
• Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients.

  2002cited by this paper
• The effect of bergamottin on diazepam plasma levels and P450 enzymes in beagle dogs.

  2002cited by this paper
• Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine

  2002cited by this paper
• Effects of Furanocoumarin Derivatives in Grapefruit Juice on Nifedipine Pharmacokinetics in Rats

  2001cited by this paper
• Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients.

  2001cited by this paper
• Seville orange juice‐felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins

  2001cited by this paper
• Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco‐2 cells and on the activity of cytochrome P450 3A4

  2000cited by this paper
• Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.

  2000cited by this paper
• Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4.

  2000cited by this paper
• Inhibition selectivity of grapefruit juice components on human cytochromes P450.

  2000cited by this paper
• Citrus Limonoids : functional chemicals in agriculture and food

  2000cited by this paper
• Analysis of Limonin and Flavonoids in Citrus Juices and Byproduct Extracts by Direct Injection and In-Line Sample Clean-Up

  2000cited by this paper
• 6′,7′‐Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P‐glycoprotein

  1999influential reference
• Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities.

  1999cited by this paper
• Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man.

  1998influential reference
• Grapefruit juice-drug interactions.

  1998cited by this paper
• Effect of Grapefruit Juice on the Pharmacokinetics of Microemulsion Cyclosporine and its Metabolite in Healthy Volunteers: Does the Formulation Difference Matter?

  1998cited by this paper
• Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice.

  1998cited by this paper
• Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.

  1997cited by this paper
• Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3.

  1997cited by this paper
• Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.

  1997cited by this paper
• Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.

  1997cited by this paper
• Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction.

  1997cited by this paper
• Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients.

  1996cited by this paper
• Effect of grapefruit juice on blood cyclosporin concentration.

  1995influential reference
• Disposition of intravenous and oral cyclosporine after administration with grapefruit juice

  1995cited by this paper
• Characterization of Orange Juice (Citrus sinensis) by Polymethoxylated Flavones

  1994cited by this paper
• Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.

  1992cited by this paper
• C18 solid-phase isolation and high-performance liquid chromatography/ultraviolet diode array determination of fully methoxylated flavones in citrus juices.

  1988cited by this paper
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

  1987cited by this paper
• Use of a Simple Solvent Optimization Program to Improve Separation of Limonin in Citrus Juices

  1986cited by this paper

• Exploring the Safety, Efficacy, and Bioactivity of Herbal Medicines: Bridging Traditional Wisdom and Modern Science in Healthcare

  2024cites this paper
• A narrative review on clinical trials showing contraindicated drugs with grapefruit juice

  2023cites this paper
• Phytochemicals That Interfere With Drug Metabolism and Transport, Modifying Plasma Concentration in Humans and Animals

  2022cites this paper
• Potential Cytochrome P450-mediated pharmacokinetic interactions between herbs, food, and dietary supplements and cancer treatments.

  2021cites this paper
• Review on Preclinical and Clinical Evidence of Food (Beverages, Fruits and Vegetables) and Drug Interactions: Mechanism and Safety

  2020cites this paper
• Transporter-Mediated Drug-Drug Interactions and Their Significance.

  2019cites this paper
• Processing grapefruit juice with γ‐cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity

  2019cites this paper
• Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood–Cerebrospinal Fluid Barrier and Blood–Brain Barrier

  2018cites this paper
• Sex-specific modulation of drug bioavailability with pharmaceutical excipients

  2018cites this paper
• Apple-Derived Nanoparticles Modulate Expression of Organic-Anion-Transporting Polypeptide (OATP) 2B1 in Caco-2 Cells.

  2018cites this paper
• Effects of Grapefruit and Pomegranate Juices on the Pharmacokinetic Properties of Dapoxetine and Midazolam in Healthy Subjects

  2017cites this paper
• Dipeptidyl peptidase IV inhibitory properties of a whey protein hydrolysate : influence of 1 fractionation , stability to simulated gastrointestinal digestion and food-drug interaction 2 3

  2017cites this paper
• Clinical determinants of calcineurin inhibitor disposition: a mechanistic review

  2016cites this paper
• Role and modulation of drug transporters in HIV-1 therapy.

  2016cites this paper
• Impact of Herbal Medicines on Conventional Drugs: An Overview

  2015cites this paper
• THE EFFCETS OF NARINGIN ON GLUCOSE TOLERANCE AND KETOACIDOSIS IN TYPE 1 DIABETES BY MURUNGA

  2015cites this paper
• Co-administration of fresh grape fruit juice (GFJ) and bergamottin prevented paracetamol induced hepatotoxicity after paracetamol overdose in rats

  2015cites this paper
• Enzyme‐ and transporter‐mediated beverage–drug interactions: An update on fruit juices and green tea

  2015influential citation
• Identification of genes associated with low furanocoumarin content in grapefruit.

  2014cites this paper
• In Vitro Dissolution Pattern of Metronidazole Film Coated Tablet in Presence of Fruit Juice

  2014cites this paper
• Review of grapefruit juice-drugs interactions mediated by intestinal CYP3A4 inhibition

  2014cites this paper
• Assessment of a Candidate Marker Constituent Predictive of a Dietary Substance–Drug Interaction: Case Study with Grapefruit Juice and CYP3A4 Drug Substrates

  2014cites this paper
• Fruit/Vegetable-Drug Interactions: Effects on Drug Metabolizing Enzymes and Drug Transporters

  2013cites this paper
• Long-Lasting Inhibitory Effect of Apple and Orange Juices, but Not Grapefruit Juice, on OATP2B1-Mediated Drug Absorption

  2013cites this paper
• Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions.

  2013cites this paper
• Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by CYP3A enzymes via in vivo and in vitro oxidation of midazolam and triazolam

  2013cites this paper
• Rapid Quantitation of Furanocoumarins and Flavonoids in Grapefruit Juice using Ultra-Performance Liquid Chromatography.

  2013cites this paper
• Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions.

  2013cites this paper
• Effects of cytochrome P450 enzyme inhibitors and inducers on the metabolism of S-ketamine

  2013cites this paper
• Food, food components, and botanicals affecting drug metabolism in transplantation.

  2013cites this paper
• Hidden Sources of Grapefruit in Beverages: Potential Interactions with Immunosuppressant Medications

  2013cites this paper
• A Modified Grapefruit Juice Eliminates Two Compound Classes as Major Mediators of the Grapefruit Juice–Fexofenadine Interaction: An In Vitro–In Vivo “Connect”

  2013cites this paper
• Review article. Assessing clinical evidence of drug interactions between citrus juices and cyclosporine

  2013cites this paper
• Integrated Approaches to Identify and Predict Pharmacokinetic-Based Dietary Substance-Drug Interactions

  2013cites this paper
• Interactions plantes et médicaments post-greffe : participation à HEDRINE

  2013cites this paper
• In vitro assessment of some traditional medications used in South Africa for pharmacokinetics drug interaction potential

  2013cites this paper
• Dipeptidyl peptidase IV inhibitory properties of a whey protein hydrolysate: Influence of fractionation, stability to simulated gastrointestinal digestion and food–drug interaction

  2013cites this paper
• Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects

  2013cites this paper
• Age-related changes in the mRNA levels of CYP1A1, CYP2B1/2 and CYP3A1 isoforms in rat small intestine

  2012cites this paper
• Mechanism-based inhibition of human Cytochrome P450-3A activity by grapefruit hybrids having low furanocoumarin content

  2012cites this paper
• An Overview of the Evidence and Mechanisms of Herb–Drug Interactions

  2012cites this paper
• Effect of Grapefruit Juice and Ritonavir on Pharmacokinetics of Lopinavir in Wistar Rats

  2012cites this paper
• Le rôle des cytochromes P450 dans les interactions médicamenteuses et environnementales rencontrées à l'officine

  2012cites this paper
• Effect of Herbal Supplement–Drug Interactions on Therapeutic Drug Monitoring

  2012cites this paper
• Human PXR-mediated induction of intestinal CYP3A4 attenuates 1α,25-dihydroxyvitamin D₃ function in human colon adenocarcinoma LS180 cells.

  2012cites this paper
• Diverse approaches for the enhancement of oral drug bioavailability

  2011cites this paper
• An overview of interactions between grapefruit juice and drugs

  2011cites this paper
• The effect of grapefruit juice on drug disposition

  2011cites this paper
• Inhibitory effects of furanocoumarin derivatives in Kampo extract medicines on P-glycoprotein at the blood-brain barrier.

  2011cites this paper
• Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters.

  2011cites this paper
• Combined ligand- and structure-based studies on inhibitors of P-glycoprotein

  2011cites this paper
• The Role of Cytochrome P450 3A Inducers and Inhibitors in the Metabolism and the Effects of Oxycodone

  2010cites this paper
• Pharmacoinformatic approaches to design natural product type ligands of ABC-transporters.

  2010cites this paper
• Improving the oral bioavailability of drugs through the design of modeled pre-systemic cytochrome P450 inhibitors

  2010cites this paper
• Influence of dietary substances on intestinal drug metabolism and transport.

  2010cites this paper
• Grapefruit juice enhances the exposure to oral oxycodone.

  2010cites this paper
• Grapefruit-Drug Interactions

  2010cites this paper
• Marginal increase of sunitinib exposure by grapefruit juice

  2010cites this paper
• Grapefruit and Other Fruit Juices Interactions with Medicines

  2009cites this paper
• Clinical pharmacology of the tyrosine kinase inhibitors imatinib and sunitinib

  2009cites this paper
• Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study

  2009cites this paper
• Clinically irrelevant effect of Grapefruit Juice on the steady-state sunitinib exposure

  2009cites this paper
• Analysis of Drug Interactions Involving Fruit Beverages and Organic Anion‐Transporting Polypeptides

  2009cites this paper
• Genetic Influences on the Pharmacokinetics of Orally and Intravenously Administered Digoxin as Exhibited by Monozygotic Twins

  2009cites this paper
• Grapefruit juice improves glycemic control but exacerbates metformin-induced lactic acidosis in non-diabetic rats.

  2009cites this paper